GleamWall
中文EN

NUTX Nutex Health Inc.

Services-Business Services, NEC · Nasdaq · SEC CIK 1479681 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-18.8%
TTM net income YoY36.5%
TTM EPS YoY20.0%
Revenue 3-yr CAGR50.9%
Net income 3-yr CAGR—

Margins

Gross margin47.8%
Operating margin39.0%
Net margin20.7%
FCF margin31.1%
EBITDA margin41.8%

Returns

ROE43.8%
ROA16.5%
ROIC (approx.)117.4%
Asset turnover0.80x

Leverage & solvency

Liabilities / assets47.6%
Debt / equity0.10x
Current ratio4.76x
Interest coverage16.21x

Cash quality & payout

Operating cash flow / net income1.57x
Accruals ratio-9.4%
Payout ratio—
Capex / revenue1.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$217.61M$210.75M$216.49M$151.68M$267.80M$243.99M$211.79M$257.62M
Gross profit$101.53M$141.28M$91.73M$46.14M$154.88M$124.92M$118.34M$141.63M
SG&A expense$17.04M$16.68M$14.38M$17.82M$11.30M$12.50M$10.04M$12.75M
Operating income$77.10M$121.72M$81.27M$30.92M$130.37M$33.68M$80.66M$114.21M
Interest expense$4.86M$4.67M$4.68M$4.98M$5.45M$5.68M$6.12M$5.05M
Pretax income$72.54M$117.08M$76.56M$25.89M$123.94M$23.73M$71.22M$108.58M
Income tax$15.20M$20.77M$13.80M$9.29M$27.14M$7.59M$20.41M$8.61M
Net income$40.23M$65.84M$46.81M$11.83M$55.44M-$17.70M$21.22M$61.70M
EBITDA$82.72M$127.03M$86.76M$36.10M$135.37M$38.93M$85.75M$119.49M
EPS (basic)5.879.586.70—8.27-2.953.7411.83
EPS (diluted)5.719.386.52—7.76-2.953.3311.12
Weighted avg. shares (diluted)7.04M7.02M7.18M—7.18M5.99M6.45M—
Balance sheet
Cash & equivalents$249.91M$205.21M$207.35M$185.57M$166.05M$96.73M$84.73M$40.64M
Receivables——————$295.08M$232.45M
Inventory$5.14M$4.21M$4.68M$2.87M$3.16M$2.27M$3.12M$2.85M
Current assets$633.24M$585.65M$579.65M$538.81M$592.65M$473.02M$401.52M$292.48M
PP&E, net$103.24M$95.70M$94.93M$94.58M$82.82M$82.92M$76.43M$77.93M
Goodwill$13.92M$13.92M$13.92M$13.92M$13.92M$13.92M$13.92M$13.92M
Intangibles$20.25M$20.58M$20.91M$21.23M$21.55M$14.88M$15.21M$15.53M
Total assets$1.03B$964.63M$957.32M$918.52M$964.52M$841.03M$761.92M$655.32M
Current liabilities$132.94M$117.22M$184.44M$157.91M$185.46M$194.87M$196.18M$154.22M
Short-term debt$8.10M$8.50M$16.73M$13.34M$18.00M$18.95M$13.63M$14.39M
Long-term debt$34.20M$31.11M$24.26M$29.17M$25.57M$20.46M$21.73M$22.47M
Total debt$42.30M$39.60M$40.99M$42.51M$43.58M$39.41M$35.37M$36.86M
Total liabilities$491.47M$457.32M$515.26M$495.09M$526.49M$504.15M$506.65M$466.79M
Shareholders' equity$435.57M$394.32M$346.29M$329.45M$317.17M$235.25M$176.95M$132.44M
Net debt-$207.61M-$165.61M-$166.36M-$143.06M-$122.47M-$57.32M-$49.36M-$3.78M
Shares outstanding6.86M6.84M6.95M7.09M6.91M6.60M5.95M5.51M
Cash flow statement
Operating cash flow$78.35M$34.20M$75.52M$70.39M$99.51M$27.26M$50.97M$54,000
Capital expenditure$5.20M$2.54M$1.20M$1.41M$302,000$751,000$64,000$394,897
Free cash flow$73.14M$31.66M$74.32M$68.98M$99.21M$26.51M$50.90M-$340,897
Investing cash flow-$5.20M-$2.54M-$1.20M-$5.07M-$302,000$196,000-$64,000-$3.34M
Financing cash flow-$26.69M-$35.19M-$49.55M-$45.79M-$29.90M-$15.45M-$6.81M-$2.99M
Depreciation & amortization$5.62M$5.32M$5.49M$5.19M$5.00M$5.25M$5.09M$5.28M
Stock-based compensation———$0$22.88M$68.96M$15.94M—
Share buybacks$1,000$18.96M$31.73M$5.00M$0$0$0—

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.